Neuland Laboratories Ltd Quarterly Results

Gross Sales

292.75

328.36

398.03

310.84

439.6

Excise Duty

0

0

0

0

0

Net Sales

292.75

328.36

398.03

310.84

439.6

Other Operating Income

0

0

0

0

0

Other Income

7.86

7.46

59.68

4.33

25.43

Total Income

300.61

335.82

457.72

315.18

465.03

Total Expenditure

258.26

277.29

311.43

248.62

316.24

PBIDT

42.34

58.54

146.28

66.56

148.79

Interest

4.58

2.35

2.22

1.06

2.67

PBDT

37.76

56.19

144.07

65.5

146.12

Depreciation

20.19

16.89

16.3

16.07

16.28

Minority Interest Before NP

0

0

0

0

0

Tax

4.37

6.02

24.95

12.21

30.58

Deferred Tax

-0.7

5.47

1.23

4.37

1.39

Reported Profit After Tax

13.9

27.81

101.59

32.84

97.87

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

13.9

27.81

101.59

32.84

97.87

Extra-ordinary Items

0

0

44.35

0

15.55

Adjusted Profit After Extra-ordinary item

13.9

27.81

57.24

32.84

82.32

EPS (Unit Curr.)

10.83

21.67

79.18

25.6

76.28

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

12.9

12.9

12.9

12.9

12.9

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.46

17.82

36.75

21.41

33.84

PBDTM(%)

12.89

17.11

36.19

21.07

33.23

PATM(%)

4.74

8.46

25.52

10.56

22.26